Exercise on the Spotlight: The Week in Health

The World Health Organization (WHO) is taking action to enhance health security during the Paris Olympics, in collaboration with international and French authorities. Additionally, the WHO has issued its first clinical guidelines to help over 750 million people quit tobacco. Meanwhile, Moderna received a US$176 million grant from the Biomedical Advanced Research and Development Authority (BARDA) to advance avian flu vaccines. In other news, experts say that declining estradiol during menopause raises osteoporosis risk, but regular exercise can help reduce it.

In local news, Claudia Sheinbaum reappointed Zoé Robledo as head of Mexico's Social Security Institute (IMSS). 

Ready? This is The Week in Health!

Bone Health During Menopause: The Role of Exercise

During menopause, declining estradiol levels accelerate bone density loss, significantly increasing the risk of osteoporosis — a condition characterized by porous and fragile bones that heightens the likelihood of fractures. To combat this risk, regular exercise is essential, according to experts. Read the whole story here. 

WHO Enhances Health Security at Paris Olympics

The WHO is actively involved in ensuring health and safety at  the upcoming Paris Olympics, alongside the International Olympic Committee (IOC) and the French Government. This effort aligns with WHO's broader mission to promote public health and physical activity. Learn more about it here. 

Sheinbaum Appoints Zoé Robledo to Continue Leading IMSS

Claudia Sheinbaum has appointed Zoé Robledo as Minister of IMSS. Robledo, who currently holds the position, will continue in this role under Sheinbaum’s administration. Read the whole story here. 

WHO Issues First Clinical Guidelines for Tobacco Cessation

The WHO’s first clinical guidelines for tobacco cessation aim to help over 750 million people quit tobacco. The guidelines include pharmacological treatments, behavioral support, and digital tools. The initiative addresses gaps in cessation services, especially in low and middle-income countries, and is expected to improve global tobacco control efforts by expanding access to quitting resources. Read the whole story here. 

BARDA Awards Moderna US$176 Million for Avian Flu Vaccine

The BARDA has awarded Moderna a US$176 million grant to advance avian flu vaccines, underscoring its commitment to pandemic preparedness. This funding, part of an October 2023 initiative, supports mRNA vaccine technology to enhance rapid-response capabilities for emerging threats, reports PharmaVoice. Learn more about it here.